Overall NEOG gets a fundamental rating of 3 out of 10. We evaluated NEOG against 186 industry peers in the Health Care Equipment & Supplies industry. While NEOG seems to be doing ok healthwise, there are quite some concerns on its profitability. NEOG is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year NEOG was profitable.
In the past year NEOG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: NEOG reported negative net income in multiple years.
Each year in the past 5 years NEOG had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -17.94%, NEOG perfoms like the industry average, outperforming 54.84% of the companies in the same industry.
The Return On Equity of NEOG (-28.64%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-17.94%
ROE	-28.64%
ROIC	N/A

ROA(3y)-10.81%

ROA(5y)-4.19%

ROE(3y)-17.92%

ROE(5y)-8.21%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NEOG's Gross Margin of 45.98% is on the low side compared to the rest of the industry. NEOG is outperformed by 60.75% of its industry peers.
In the last couple of years the Gross Margin of NEOG has remained more or less at the same level.
NEOG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	45.98%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.72%

GM growth 5Y0.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NEOG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NEOG has about the same amount of shares outstanding.
Compared to 5 years ago, NEOG has more shares outstanding
NEOG has a worse debt/assets ratio than last year.

2.2 Solvency

NEOG has an Altman-Z score of 1.20. This is a bad value and indicates that NEOG is not financially healthy and even has some risk of bankruptcy.
NEOG has a Altman-Z score (1.20) which is comparable to the rest of the industry.
NEOG has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.38, NEOG perfoms like the industry average, outperforming 47.85% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.38
Debt/FCF	N/A
Altman-Z	1.2

ROIC/WACCN/A

WACC10.17%

2.3 Liquidity

A Current Ratio of 3.91 indicates that NEOG has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.91, NEOG is doing good in the industry, outperforming 67.74% of the companies in the same industry.
NEOG has a Quick Ratio of 2.80. This indicates that NEOG is financially healthy and has no problem in meeting its short term obligations.
NEOG has a Quick ratio of 2.80. This is in the better half of the industry: NEOG outperforms 63.98% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.91
Quick Ratio	2.8

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

NEOG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -27.50%.
NEOG shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.20% yearly.
The Revenue has decreased by -3.67% in the past year.
Measured over the past years, NEOG shows a quite strong growth in Revenue. The Revenue has been growing by 16.43% on average per year.

EPS 1Y (TTM)-27.5%

EPS 3Y-9.82%

EPS 5Y-10.2%

EPS Q2Q%-9.09%

Revenue 1Y (TTM)-3.67%

Revenue growth 3Y19.28%

Revenue growth 5Y16.43%

Sales Q2Q%-2.84%

3.2 Future

The Earnings Per Share is expected to grow by 14.62% on average over the next years. This is quite good.
Based on estimates for the next years, NEOG will show a small growth in Revenue. The Revenue will grow by 0.72% on average per year.

EPS Next Y-25.82%

EPS Next 2Y2.51%

EPS Next 3Y4.1%

EPS Next 5Y14.62%

Revenue Next Year-4.5%

Revenue Next 2Y-1.3%

Revenue Next 3Y-0.81%

Revenue Next 5Y0.72%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 33.79 indicates a quite expensive valuation of NEOG.
Compared to the rest of the industry, the Price/Earnings ratio of NEOG indicates a somewhat cheap valuation: NEOG is cheaper than 72.58% of the companies listed in the same industry.
NEOG's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.21.
Based on the Price/Forward Earnings ratio of 28.26, the valuation of NEOG can be described as expensive.
Based on the Price/Forward Earnings ratio, NEOG is valued a bit cheaper than 74.19% of the companies in the same industry.
NEOG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.26.

		Industry Rank	Sector Rank
PE	33.79
Fwd PE	28.26

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NEOG indicates a somewhat cheap valuation: NEOG is cheaper than 70.97% of the companies listed in the same industry.